COPENHAGEN, Jan 31 (Reuters) - The world's biggest insulin producer Novo Nordisk raised sales and profit forecasts for 2013 on hopes its new Tresiba drug will soon win approval in the United States ...
Danish pharmaceutical company Novo Nordisk announced last week that its diabetes-fighting insulin drug Ryzodeg has been approved for sale in Japan by the Japanese Ministry of Health, Labour, and ...
* Says Novo Nordisk submits application to the European Medicines Agency (EMA) for including data from the two SWITCH trials in the Tresiba label Sign up here. * Says during the first SWITCH study's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback